Apellis Pharmaceuticals, Inc. (APLS) Q3 Earnings and Revenues Top Estimates

Apellis Pharmaceuticals, Inc. (APLS) came out with quarterly earnings of $1.67 per share, beating the Zacks Consensus Estimate of$ 1.03 per share. This compares to a loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +62.14%. A quarter ago, it was expected that this company would post a loss of$ 0.44 per share when it actually produced a loss of $0.33, delivering a surprise of +25%.Over the last four quarters, the c ...